Developer docs
API playgroundTry for free, no card

Search company profiles

Bonumose

Full company profile

uuid0000y73

Namestring
Bonumose
Legal namestring
Bonumose, Inc.
Websiteurl
bonumose.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Bonumose, Inc. is a privately held food ingredient company headquartered in Charlottesville, Virginia, founded in 2016 by Ed Rogers (CEO) and Dr. Daniel Wichelecki (CSO). The company produces tagatose, a naturally occurring 'rare sugar' sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into tagatose crystals at high yield and purity — a process Bonumose describes as the first to make tagatose scalable and affordable for mass-market use. The technology platform extends beyond tagatose to other rare ingredients targeted at food, supplements, animal feed, crop protection, and soil health. Tagatose carries an unusually strong regulatory profile: GRAS status, an FDA-approved dental caries reduction health claim, an EFSA-approved blood glucose health claim, NutraStrong Prebiotic Verified certification, and (as of April 2026) an FDA exemption from 'added sugar' labeling.

The company operates a hybrid go-to-market model. The primary B2B revenue stream is ingredient sales to food and beverage manufacturers for use in reformulated consumer products; the only named customer in the available data is San Martín (Greek yogurt with LGG probiotic). A secondary D2C channel sells Bonumose-branded Granulated Tagatose directly to consumers through Amazon for home cooking and baking use. Pricing for B2B contracts is not publicly disclosed and is presumed to be quote-based, while the consumer product is sold at unit retail pricing on Amazon. Strategic investors include Hershey and American Sugar Refining (both investing in February 2021), and the company signed a global co-development and scale-up agreement with Roquette in July 2024 to broaden production capacity and geographic reach. Manufacturing is conducted at a new commercial-scale facility opened in March 2023 in the Charlottesville area.

Cumulatively, Bonumose has raised approximately $49 million across six funding rounds between 2016 and 2023. Recognition includes World Economic Forum Technology Pioneer status (May 2022). Operational signals — facility commissioning, regulatory wins, a major strategic partnership with a top-tier global ingredient supplier, and ongoing capital deployment — point to a company transitioning from R&D and pilot scale into early commercial production, though no revenue figures are publicly disclosed and customer concentration outside of strategic partners is not visible.

Short descriptiontext

Bonumose produces tagatose, a low-calorie rare sugar sweetener, via a proprietary enzymatic platform that converts plant starch into scalable tagatose crystals. The company sells the ingredient to food and beverage manufacturers and a branded retail product direct-to-consumer via Amazon.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCharlottesville, United States
HQ citystring
Charlottesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare sugar production, food ingredient manufacturing, enzyme-catalyzed sweeteners, sugar replacement ingredients, prebiotic sweetener
Industry1 code
PRIMARYAFAJAAAK
Rare Sugars (Allulose, Tagatose, Isomaltulose/Palatinose)
Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)
NAICS code2 codes
  • Sugar Manufacturing31131
  • Sugar and Confectionery Product Manufacturing3113
SIC code1 code
  • Sugar & Confectionery Products2060
Product category
Food Ingredients (Rare Sugar Sweetener)
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1B2B Ingredient Sales
TypeTransaction Fee
Description

Bonumose sells tagatose as an ingredient to food and beverage manufacturers for use in consumer products. This is the primary revenue stream, targeting globally-relevant industries including mainstream packaged foods.

bonumose.com
2Consumer E-commerce (Amazon)
TypeOne Time License
Description

Bonumose sells its own branded granulated tagatose product directly to consumers via Amazon, enabling individuals to purchase tagatose for home cooking, baking, and everyday recipes.

bonumose.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales
Pricing details1 tier
1Amazon retail product for individual consumers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Bonumose Granulated Tagatose is sold on Amazon as a retail consumer product (1 lb / 16 oz jar). Specific price per unit is available on the Amazon listing page.

bonumose.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bonumose produces tagatose, a rare sugar sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into pure tagatose crystals at commercial scale. The company sells tagatose as a B2B ingredient to food and beverage manufacturers for use in consumer packaged goods, and as a finished branded Granulated Tagatose product to individual consumers through Amazon. Tagatose offers 90% of sugar's sweetness, glycemic index of 3, 38% of sugar's calories, and prebiotic and tooth-friendly benefits backed by FDA and EFSA health claims.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Glycemic index of 3 (vs. 68 for table sugar and 100 for glucose)
+3 more records
Product overview1 text field

Bonumose is a food ingredient company that produces tagatose, a rare sugar sweetener, using proprietary enzymatic technology to convert abundant plant starch into a scalable and affordable sugar alternative. The company offers its core ingredient product (Tagatose/Granulated Tagatose) both directly to food manufacturers as an ingredient and to consumers via Amazon. The portfolio includes the main Tagatose product along with value-added offerings like Brown Tagatose (a tagatose-molasses blend for baking) and a collection of recipes demonstrating tagatose's culinary applications. Tagatose serves as a direct sugar replacement in foods and beverages with proven health benefits including prebiotic properties, ultra-low glycemic impact, and FDA/EFSA-approved health claims.

Product and service2 records
1Granulated Tagatose
CategoryFood Ingredient / Sweetener
Description

A 1:1 sugar replacement sweetener produced via proprietary enzymatic conversion of plant starch into tagatose crystals. Glycemic index of 3, 38% of sugar's calories, prebiotic, tooth-friendly, with FDA and EFSA approved health claims. Sold as a bulk B2B ingredient to food and beverage manufacturers and as a branded 1 lb / 16 oz retail jar on Amazon for individual consumers for home cooking and baking.

2Brown Tagatose
CategoryFood Ingredient / Sweetener
Description

A tagatose-molasses blend offered as a value-added baking variant of Bonumose's core tagatose product, providing browning and flavor functionality for recipes.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-08
Description

Roquette and Bonumose signed a global cooperation agreement in July 2024 to enhance the production of tagatose, a natural sweetener with proven health benefits. The partnership focuses on technological and scale-up development to meet growing demand for healthier sugar alternatives as food formulators increasingly adopt natural sweeteners.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global food ingredient manufacturer producing allulose (Dolcia Prima Allulose) and other specialty sweeteners. Tate & Lyle competes head-to-head with Bonumose in the rare-sugar/low-calorie sweetener category serving CPG and foodservice customers.

TypeBroad incumbent
Description

Global ingredients company combining nutrition, health, and flavors expertise, including enzyme technology and sweetener solutions. DSM-Firmenich competes with Bonumose in the broader food ingredient space and has the R&D capability to develop alternative tagatose pathways.

3SweeGen
TypeEmerging player
Description

Specialty sweetener company focused on next-generation, nature-based sweeteners including stevia and rare sugars. SweeGen competes with Bonumose for B2B food and beverage accounts seeking reduced-sugar ingredient solutions.

TypeBroad incumbent
Description

Global leader in plant-based ingredients (starches, polyols including sorbitol, mannitol, xylitol) and Bonumose's strategic partner for tagatose scale-up. Roquette's polyol sweetener portfolio places it in direct competition with Bonumose in food/beverage ingredient markets.

TypeEmerging player
Description

Biotechnology company using fermentation to produce rare and specialty ingredients including sweeteners. Conagen's bioproduction capabilities position it as a potential competitor or partner in the rare-sugar space where Bonumose operates.

TypeBroad incumbent
Description

Global food ingredient and agricultural processor with a sweeteners and starches business serving food, beverage, and industrial customers. ADM's scale and ingredient breadth create overlapping competition with Bonumose in CPG sweetener markets.

TypeEmerging player
Description

Synthetic biology company producing fermentation-derived ingredients including sugar alternatives. Amyris's fermentation technology represents an alternative production pathway for rare sugars and competes with Bonumose's enzymatic approach.

TypeBroad incumbent
Description

One of the largest global food ingredient and agricultural commodity companies, producing sweeteners, starches, and specialty food ingredients. Cargill's scale and customer relationships in food manufacturing make it both a potential partner and competitor for Bonumose.

TypeDirect peer
Description

Global ingredient solutions company producing Astraea Allulose and a broad portfolio of sweeteners and starches. Ingredion directly competes with Bonumose for food and beverage manufacturer accounts seeking rare-sugar and sugar-reduction solutions.

TypeDirect peer
Description

Japanese specialty ingredient manufacturer and the largest producer of allulose (a competing rare sugar) globally. Matsutani is a direct competitor in the rare-sugar sweetener category targeting food and beverage manufacturers seeking low-calorie alternatives to sugar.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bonumose

Food Ingredients (Rare Sugar Sweetener)bonumose.com

Bonumose produces tagatose, a low-calorie rare sugar sweetener, via a proprietary enzymatic platform that converts plant starch into scalable tagatose crystals. The company sells the ingredient to food and beverage manufacturers and a branded retail product direct-to-consumer via Amazon.

What Bonumose does

Bonumose, Inc. is a privately held food ingredient company headquartered in Charlottesville, Virginia, founded in 2016 by Ed Rogers (CEO) and Dr. Daniel Wichelecki (CSO). The company produces tagatose, a naturally occurring 'rare sugar' sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into tagatose crystals at high yield and purity — a process Bonumose describes as the first to make tagatose scalable and affordable for mass-market use. The technology platform extends beyond tagatose to other rare ingredients targeted at food, supplements, animal feed, crop protection, and soil health. Tagatose carries an unusually strong regulatory profile: GRAS status, an FDA-approved dental caries reduction health claim, an EFSA-approved blood glucose health claim, NutraStrong Prebiotic Verified certification, and (as of April 2026) an FDA exemption from 'added sugar' labeling.

The company operates a hybrid go-to-market model. The primary B2B revenue stream is ingredient sales to food and beverage manufacturers for use in reformulated consumer products; the only named customer in the available data is San Martín (Greek yogurt with LGG probiotic). A secondary D2C channel sells Bonumose-branded Granulated Tagatose directly to consumers through Amazon for home cooking and baking use. Pricing for B2B contracts is not publicly disclosed and is presumed to be quote-based, while the consumer product is sold at unit retail pricing on Amazon. Strategic investors include Hershey and American Sugar Refining (both investing in February 2021), and the company signed a global co-development and scale-up agreement with Roquette in July 2024 to broaden production capacity and geographic reach. Manufacturing is conducted at a new commercial-scale facility opened in March 2023 in the Charlottesville area.

Cumulatively, Bonumose has raised approximately $49 million across six funding rounds between 2016 and 2023. Recognition includes World Economic Forum Technology Pioneer status (May 2022). Operational signals — facility commissioning, regulatory wins, a major strategic partnership with a top-tier global ingredient supplier, and ongoing capital deployment — point to a company transitioning from R&D and pilot scale into early commercial production, though no revenue figures are publicly disclosed and customer concentration outside of strategic partners is not visible.

Bonumose firmographics

Firmographics
Name
Bonumose
Legal name
Bonumose, Inc.
Website
https://bonumose.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Bonumose produces tagatose, a low-calorie rare sugar sweetener, via a proprietary enzymatic platform that converts plant starch into scalable tagatose crystals. The company sells the ingredient to food and beverage manufacturers and a branded retail product direct-to-consumer via Amazon.
Ownership category
akta.pro rank

Bonumose industry classification

Industry
Product category
Food Ingredients (Rare Sugar Sweetener)
NAICS
Sugar Manufacturing (31131), Sugar and Confectionery Product Manufacturing (3113)
SIC
Sugar & Confectionery Products (2060)
akta.pro industry
PRIMARYAFAJAAAK
Rare Sugars (Allulose, Tagatose, Isomaltulose/Palatinose)
Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)

Keywords

  • Rare sugar production
  • Food ingredient manufacturing
  • Enzyme-catalyzed sweeteners
  • Sugar replacement ingredients
  • Prebiotic sweetener

Where Bonumose is headquartered

Location

Headquarters

HQ city
Charlottesville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Bonumose business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales

Revenue model

  1. B2B Ingredient Sales: Bonumose sells tagatose as an ingredient to food and beverage manufacturers for use in consumer products. This is the primary revenue stream, targeting globally-relevant industries including mainstream packaged foods.
  2. Consumer E-commerce (Amazon): Bonumose sells its own branded granulated tagatose product directly to consumers via Amazon, enabling individuals to purchase tagatose for home cooking, baking, and everyday recipes.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goAmazon retail product for individual consumers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Bonumose product offering

Product offering

Core offering

Bonumose produces tagatose, a rare sugar sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into pure tagatose crystals at commercial scale. The company sells tagatose as a B2B ingredient to food and beverage manufacturers for use in consumer packaged goods, and as a finished branded Granulated Tagatose product to individual consumers through Amazon. Tagatose offers 90% of sugar's sweetness, glycemic index of 3, 38% of sugar's calories, and prebiotic and tooth-friendly benefits backed by FDA and EFSA health claims.

Product overview

Bonumose is a food ingredient company that produces tagatose, a rare sugar sweetener, using proprietary enzymatic technology to convert abundant plant starch into a scalable and affordable sugar alternative. The company offers its core ingredient product (Tagatose/Granulated Tagatose) both directly to food manufacturers as an ingredient and to consumers via Amazon. The portfolio includes the main Tagatose product along with value-added offerings like Brown Tagatose (a tagatose-molasses blend for baking) and a collection of recipes demonstrating tagatose's culinary applications. Tagatose serves as a direct sugar replacement in foods and beverages with proven health benefits including prebiotic properties, ultra-low glycemic impact, and FDA/EFSA-approved health claims.

Differentiator

Problem solved

Functional benefit

Products and services

  • Granulated Tagatose A 1:1 sugar replacement sweetener produced via proprietary enzymatic conversion of plant starch into tagatose crystals. Glycemic index of 3, 38% of sugar's calories, prebiotic, tooth-friendly, with FDA and EFSA approved health claims. Sold as a bulk B2B ingredient to food and beverage manufacturers and as a branded 1 lb / 16 oz retail jar on Amazon for individual consumers for home cooking and baking.
  • Brown Tagatose A tagatose-molasses blend offered as a value-added baking variant of Bonumose's core tagatose product, providing browning and flavor functionality for recipes.

Quantifiable outcome

  • Glycemic index of 3 (vs. 68 for table sugar and 100 for glucose)
  • +3 more outcomes

Companies that use Bonumose

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Bonumose technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Bonumose partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • RoquettecoreStrategic or Co-development Partner · 8 July 2024Roquette and Bonumose signed a global cooperation agreement in July 2024 to enhance the production of tagatose, a natural sweetener with proven health benefits. The partnership focuses on technological and scale-up development to meet growing demand for healthier sugar alternatives as food formulators increasingly adopt natural sweeteners.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Bonumose competitors and assessment

Company assessment

Direct peers

  • Tate & Lyle: Global food ingredient manufacturer producing allulose (Dolcia Prima Allulose) and other specialty sweeteners. Tate & Lyle competes head-to-head with Bonumose in the rare-sugar/low-calorie sweetener category serving CPG and foodservice customers.
  • Ingredion: Global ingredient solutions company producing Astraea Allulose and a broad portfolio of sweeteners and starches. Ingredion directly competes with Bonumose for food and beverage manufacturer accounts seeking rare-sugar and sugar-reduction solutions.
  • Matsutani Chemical: Japanese specialty ingredient manufacturer and the largest producer of allulose (a competing rare sugar) globally. Matsutani is a direct competitor in the rare-sugar sweetener category targeting food and beverage manufacturers seeking low-calorie alternatives to sugar.

Broad incumbents

  • DSM-Firmenich: Global ingredients company combining nutrition, health, and flavors expertise, including enzyme technology and sweetener solutions. DSM-Firmenich competes with Bonumose in the broader food ingredient space and has the R&D capability to develop alternative tagatose pathways.
  • Roquette: Global leader in plant-based ingredients (starches, polyols including sorbitol, mannitol, xylitol) and Bonumose's strategic partner for tagatose scale-up. Roquette's polyol sweetener portfolio places it in direct competition with Bonumose in food/beverage ingredient markets.
  • ADM: Global food ingredient and agricultural processor with a sweeteners and starches business serving food, beverage, and industrial customers. ADM's scale and ingredient breadth create overlapping competition with Bonumose in CPG sweetener markets.
  • Cargill: One of the largest global food ingredient and agricultural commodity companies, producing sweeteners, starches, and specialty food ingredients. Cargill's scale and customer relationships in food manufacturing make it both a potential partner and competitor for Bonumose.

Emerging players

  • SweeGen: Specialty sweetener company focused on next-generation, nature-based sweeteners including stevia and rare sugars. SweeGen competes with Bonumose for B2B food and beverage accounts seeking reduced-sugar ingredient solutions.
  • Conagen: Biotechnology company using fermentation to produce rare and specialty ingredients including sweeteners. Conagen's bioproduction capabilities position it as a potential competitor or partner in the rare-sugar space where Bonumose operates.
  • Amyris: Synthetic biology company producing fermentation-derived ingredients including sugar alternatives. Amyris's fermentation technology represents an alternative production pathway for rare sugars and competes with Bonumose's enzymatic approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Bonumose social profiles

Digital presence

Bonumose compliance and trust

Trust signal

Compliance4 records

Bonumose financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bonumose leadership team

Management profile

Number of profiles

Profiles2 records

Bonumose funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bonumose M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bonumose

What does Bonumose do?

Bonumose produces tagatose, a rare sugar sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into pure tagatose crystals at commercial scale. The company sells tagatose as a B2B ingredient to food and beverage manufacturers for use in consumer packaged goods, and as a finished branded Granulated Tagatose product to individual consumers through Amazon. Tagatose offers 90% of sugar's sweetness, glycemic index of 3, 38% of sugar's calories, and prebiotic and tooth-friendly benefits backed by FDA and EFSA health claims.

Is Bonumose a public or private company?

Bonumose is a private company. It is classified as venture growth investor backed and is currently operating.

When was Bonumose founded?

Bonumose was founded in 2016. It employs 11 to 50 people.

Where is Bonumose based?

Bonumose is headquartered in Charlottesville, United States, in the North America region.

How does Bonumose make money?

Two revenue lines are on record. B2B Ingredient Sales are the primary driver. The others are consumer E-commerce (Amazon).

Who are Bonumose's main competitors?

Direct peers on record are Tate & Lyle, Ingredion and Matsutani Chemical. Broad incumbents are DSM-Firmenich, Roquette, ADM and Cargill. Emerging players are SweeGen, Conagen and Amyris.

Does Bonumose have an API?

No public API is recorded for Bonumose.

What industry is Bonumose in?

Bonumose's product category is Food Ingredients (Rare Sugar Sweetener). Its primary akta.pro industry code is AFAJAAAK, Rare Sugars (Allulose, Tagatose, Isomaltulose/Palatinose). Its NAICS code is 31131 and its SIC code is 2060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AgFunderNewsFDA exempts tagatose from added sugar labelingThe US Food and Drug Administration (FDA) has exempted the low-calorie sweetener tagatose from 'added sugar' labeling requirements on food labels, reversing a 2022 denial following a lawsuit by startup Bonumose. The FDA acknowledged tagatose's health benefits and lower caloric value, recognizing its potential to serve as a healthier alternative to traditional sugars. This regulatory shift is expected to significantly boost market interest and production scalability for manufacturers like Bonumose and its partners.EIN PresswireAllulose Market Size Worth USD 242.69 Million by 2032 | Trends, Share, Demand, Forecast & Competitive AnalysisThe Global Allulose Market is projected to grow from USD 59.54 million in 2024 to USD 242.69 million by 2032, at a compound annual growth rate of 19.2%, driven by increasing demand for low-calorie sweeteners, natural sugar alternatives, and functional foods. Key industry developments include Quest Nutrition's March 2025 launch of a premium protein RTD line, Cargill's recognition as a finalist in the Global Good Awards for its EverSweet sweetener platform, and Bonumose LLC's 2023 strategic investment from Symrise to scale rare sugar production. The market faces potential headwinds from low-cost synthetic sugar alternatives and limited long-term health research on Allulose.Fact.MRGlobal Market Analysis Report - 2035A market analysis report projects the global tagatose market to grow from USD 180.0 million in 2025 to USD 520.0 million by 2035, driven by rising consumer demand for low-calorie sweeteners and health-conscious food formulations. The report identifies key growth drivers such as obesity prevention initiatives and technological advancements in production, while noting high manufacturing costs as a primary restraint. Leading industry players including Bonumose, CJ CheilJedang, and ADM are highlighted for their strategic investments in production facilities and application development.PR NewswireAllozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement IngredientsAllozymes and Bonumose have announced preliminary results from their collaboration to optimize key enzymes for Bonumose's ingredient production process, using Allozymes' microfluidics-based protein engineering platform that can analyze up to 20 million enzyme variants daily. The companies report promising early results in improving process efficiency and scalability for producing healthy food and supplement ingredients from plant-based feedstocks. Both companies view this partnership as a critical step toward demonstrating how enzyme innovation can accelerate sustainable and cost-effective ingredient production for global needs.PR NewswireAllozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement IngredientsAllozymes and Bonumose announced preliminary results of improvements to key enzymes for Bonumose's ingredient production process, leveraging Allozymes' microfluidics-based protein engineering platform. The platform enables analysis of up to 20 million enzyme variants daily, significantly reducing development timelines and improving process efficiency for producing healthy food and supplement ingredients from plant-based feedstocks. Both companies characterized the early results as promising and on track to meet their developmental objectives for sustainable and cost-effective ingredient production.The Manila TimesAllozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement IngredientsAllozymes and Bonumose announced preliminary results of enzyme improvements for Bonumose's ingredient production, using Allozymes' microfluidics platform to screen up to 20 million variants daily. The collaboration aims to enhance process efficiency and scalability for producing high-purity monosaccharides from plant-based feedstocks.YahooAllozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement IngredientsAllozymes and Bonumose announced preliminary results from optimizing key enzymes for Bonumose's ingredient production, using Allozymes' microfluidics platform to screen up to 20 million variants daily. The collaboration aims to improve process efficiency and scalability for producing high-purity monosaccharides from plant-based feedstocks.UConn TodayUConn Study Shows Tagatose May Combat Antibiotic-Resistant C. difficile InfectionsA University of Connecticut study found that tagatose, a plant-based sugar alternative, significantly reduced symptoms and severity of antibiotic-resistant C. difficile infections in mice while proving safe for the animals. Bonumose, Inc., an enzyme solutions company, is collaborating with UConn to explore the commercial potential of this research under a sponsored agreement holding an option license to the technology. The findings suggest tagatose may serve as a novel nutraceutical approach by promoting gut health and inhibiting bacterial toxins.AgFunderNewsSugar replacement: Bonumose secures preliminary victory over ‘arbitrary and capricious’ FDA on tagatose labelingVirginia-based startup Bonumose secured a preliminary legal victory in the U.S. District Court for the District of Columbia, which ruled that the FDA acted arbitrarily and capriciously by denying its petition to reclassify tagatose from an 'added sugar' to a non-added sweetener on food labels. The court vacated the FDA's 2022 denial order and remanded the case for further proceedings, citing inconsistent reasoning compared to the agency's treatment of the similar rare sugar allulose. This ruling does not immediately change labeling requirements but compels the FDA to address the issue promptly under First Amendment constraints regarding compelled speech.